Peter Bart: The New Yorker’s Opening Was A Flop, But Magazine’s Centenary Is A Study In Survival
Despite a downturn in the magazine industry, The New Yorker with its 1.23 million subscribers is a study in survival, Peter ...
Street vendors, who make up a substantial portion of the informal workforce in many low-income and middle-income countries, remain largely excluded from formal health insurance coverage, which poses a ...
Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
A couple whose son was among one of the first patients in the world to receive an innovative treatment for a rare genetic ...
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic ...
An experimental trial of gene therapy has helped four toddlers - born with one of the most severe forms of childhood ...
A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and ...
In 1998, Wakefield was the lead author on a paper, published in the respected medical journal The Lancet, that claimed there ...
The study showed about 740,000 suicides are reported annually which means one person dies on average every 43 seconds by suicide.
The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results